NNOX
Nano-X Imaging Ltd.
NASDAQ · Healthcare · Medical - Devices · IL
$0.83
+16.43%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 14.5M | 13.0M | 11.3M | 9.9M | 8.6M |
| Cost of Revenue | 27.0M | 25.8M | 21.9M | 16.5M | 15.5M |
| Gross Profit | (12.4M) | (12.8M) | (10.6M) | (6.6M) | (6.9M) |
| Operating Expenses | |||||
| R&D Expense | 14.3M | 19.2M | 20.2M | 26.0M | 26.5M |
| SG&A Expense | 28.4M | 27.1M | 25.7M | 28.4M | 45.6M |
| General & Admin Expense | 24.6M | 24.5M | 24.1M | 26.0M | 41.3M |
| Selling & Marketing Expense | 3.9M | 2.6M | 1.7M | 2.4M | 4.4M |
| Other Expenses | 6.3M | 1.6M | 206.0K | 1.6M | 191.0K |
| Total Operating Expenses | 49.0M | 47.9M | 46.1M | 56.0M | 72.3M |
| Cost and Expenses | 75.9M | 73.7M | 68.0M | 72.5M | 87.8M |
| Operating Income (EBIT) | (61.4M) | (60.7M) | (56.7M) | (62.6M) | (109.7M) |
| Non-Operating | |||||
| Interest Income | 1.2M | 1.4M | 2.9M | 1.7M | 789.0K |
| Interest Expense | 149.0K | — | — | — | — |
| Net Interest Income | 1.0M | 1.4M | 2.9M | 1.7M | 789.0K |
| Other Non-Op Income/Expense | (16.3M) | (16.1M) | 2.9M | 1.5M | (14.7M) |
| Non-Operating Income (excl Interest) | — | — | — | (2.9M) | (15.0M) |
| EBT (Pre-Tax Income) | (77.7M) | (76.8M) | (53.9M) | (61.1M) | (108.9M) |
| Income Tax Expense | (1.6M) | (1.8M) | (358.0K) | (339.0K) | (3.7M) |
| Bottom Line | |||||
| Net Income | (76.0M) | (75.0M) | (53.5M) | (60.8M) | (105.2M) |
| Earnings from Cont. Ops | (76.0M) | (75.0M) | (53.5M) | (60.8M) | (113.2M) |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | (76.0M) | (75.0M) | (53.5M) | (60.8M) | (113.2M) |
| Per Share | |||||
| Basic EPS | ($1.14) | ($1.16) | ($0.91) | ($1.08) | ($2.01) |
| Diluted EPS | ($1.14) | ($1.16) | ($0.91) | ($1.08) | ($2.01) |
| Revenue Per Share | $0.21 | $0.20 | $0.19 | $0.18 | $0.16 |
| Shares | |||||
| Basic Shares Outstanding | 69.6M | 64.8M | 58.6M | 56.4M | 52.2M |
| Diluted Shares Outstanding | 69.6M | 64.8M | 58.6M | 56.4M | 52.2M |
| Profitability Metrics | |||||
| EBITDA | (49.8M) | (49.0M) | (45.0M) | (47.7M) | (75.7M) |
| D&A | 11.6M | 11.7M | 11.7M | 11.8M | 11.5M |
| EBIT | (61.4M) | (60.7M) | (56.7M) | (59.7M) | (87.2M) |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026